About the Journal
The Journal of Oncology and Cancer Research is a peer-reviewed, international, open-access journal dedicated to accelerating progress in the prevention, diagnosis, treatment, and management of cancer across all disciplines and geographies. As oncology continues to evolve with breakthroughs in molecular biology, immunotherapy, personalized medicine, and digital health, Journal of Oncology and Cancer Research offers a dynamic platform for researchers, clinicians, oncologists, and healthcare professionals to publish cutting-edge findings that directly impact cancer care and patient outcomes. The journal welcomes original research, systematic reviews, meta-analyses, clinical trials, case reports, and translational studies that advance our understanding of tumor biology and improve cancer care practices worldwide.
Journal of Oncology and Cancer Research covers a broad spectrum of topics, including medical, surgical, and radiation oncology; hematologic malignancies; cancer genetics and epigenetics; cancer immunotherapy; targeted therapies; precision oncology; early detection and biomarkers; oncologic imaging; supportive and palliative care; survivorship; cancer prevention and screening; and health disparities in oncology. We are particularly interested in high-impact, interdisciplinary studies that integrate basic science, clinical practice, and population health, as well as innovations in AI-based diagnostics, wearable technology, nanomedicine in oncology, and real-world evidence from diverse care settings.
All submissions undergo a rigorous double-blind peer-review process overseen by an international editorial board to ensure scientific excellence, ethical integrity, and relevance to a global readership. Through our open-access model, every published article is freely accessible to clinicians, researchers, educators, policymakers, and patients alike, empowering informed decisions and inclusive knowledge sharing across the cancer care continuum. Journal of Oncology and Cancer Research also actively promotes research from low- and middle-income countries, acknowledging the urgent need for global equity in oncology research and access to treatment.
In the face of a growing global cancer burden, the Journal of Oncology and Cancer Research stands as a committed ally in the fight against cancer a space for thought leadership, scientific discovery, and collaboration across borders. Whether you're uncovering molecular mechanisms of metastasis, piloting community-based cancer screening, evaluating novel therapeutics, or advocating for policy change, Journal of Oncology and Cancer Research is your platform to amplify impact, influence care, and save lives.
Aim and Scope
The Journal of Oncology and Cancer Research (JOCR) publishes high-quality original research articles, reviews, short communications, case studies, and clinical perspectives that address every aspect of cancer biology, oncology practice, and translational cancer research. We welcome submissions across a diverse range of thematic areas, including (but not limited to):
Cancer Biology & Tumor Microenvironment
- Molecular mechanisms of carcinogenesis and tumor progression
- Tumor microenvironment, angiogenesis, metastasis, and immune evasion
- Cancer stem cells, cellular signaling pathways, and epigenetic regulation
- Genomics, proteomics, metabolomics, and biomarker discovery
Medical, Surgical & Radiation Oncology
- Advances in chemotherapy, radiotherapy, immunotherapy, and targeted therapy
- Precision oncology, pharmacogenomics, and personalized medicine
- Minimally invasive cancer surgeries and interventional oncology
- Treatment toxicity management and supportive oncology care
Hematologic Malignancies
- · Leukemia, lymphoma, myeloma, and myeloproliferative neoplasms
- · Bone marrow transplantation, cell therapy, and graft-versus-host disease
- · Hematologic cancer diagnostics, imaging, and molecular classification
- · Advances in CAR-T therapy and immuno-oncology approaches
Solid Tumors & Organ-Specific Cancers
- Breast, lung, colorectal, prostate, and gynecologic cancers
- Head and neck cancers, brain tumors, gastrointestinal malignancies
- Sarcomas, melanoma, pediatric cancers, and rare tumors Tumor staging, imaging, surgical strategies, and integrated management
Cancer Immunology & Immunotherapy
- Immune checkpoint inhibitors, vaccines, monoclonal antibodies
- Tumor-infiltrating lymphocytes, cytokine therapy, and NK-cell research
- Immune microenvironment profiling and immune-escape mechanisms
- Emerging immunotherapeutic technologies and clinical applications
Cancer Prevention, Screening & Early Detection
- Population-based cancer screening programs and diagnostic innovations
- Lifestyle, environmental, and genetic risk factors
- Early detection biomarkers, liquid biopsy, and advanced imaging
- Public health strategies and preventive oncology
Translational & Experimental Oncology
- Preclinical drug discovery, nanomedicine, and experimental therapeutics
- Organoids, 3D models, xenografts, and animal models of cancer Mechanistic studies, pathway targeting, and drug resistance research
- Translational approaches bridging laboratory findings to clinical practice
Psycho-Oncology, Survivorship & Palliative Care
- Quality of life, symptom management, and long-term survivorship
- Psychosocial oncology, mental health, and caregiver support
- Pain management, end-of-life care, and palliative interventions
- Rehabilitation, nutrition, and holistic cancer care
Oncology Technology, AI & Innovations
- AI/ML in cancer diagnosis, prognosis, and treatment planning
- Radiomics, digital pathology, and computational oncology
- Wearables, remote monitoring, and tele-oncology applications
- Innovative medical technologies and future cancer care advancements
Editorial and Peer-Review Policy
Journal of Oncology and Cancer Research employs a single-blind peer-review process to maintain fairness,
scientific integrity, and the quality of published work.
Key Features:
- Every manuscript is assessed by at least two independent subject experts, along with editorial oversight.
- Reviewers can see author details, but the identities of the authors remain hidden from them.
- The review criteria focus on originality, technical strength, methodological accuracy, ethical compliance, clarity, and relevance to the field of nanoscience.
- All submissions go through plagiarism checks and ethical evaluations before the peer-review process.
- Final decisions on publication are made by the handling editor, based on the reviewers' evaluations and the overall quality of the manuscript.
Publication Frequency & Format
This journal comes out three times a year. Once articles are accepted, they're quickly made available online in both HTML and PDF formats, ensuring fast and easy access to research findings.
Open Access Policy
Journal of Oncology and Cancer Research embraces a gold open access model, meaning all published articles are freely accessible to everyone. Authors retain the copyright to their work, shared under a suitable open-access license to promote transparency, collaboration, and global knowledge-sharing.
Indexing & Archiving
The journal aims to be included in well-known scientific indexing and abstracting databases. All content is preserved through trusted archiving systems to ensure long-term accessibility and discoverability.
For Manuscript Submission
Authors can submit their manuscripts through the journal's Online Submission System
(Submit Manuscript) or by emailing the Editorial Office at
support@globalmeetx.com.
Submitted manuscripts must adhere to the Journal of Oncology and Cancer Research Author Guidelines, which cover structure, formatting,
ethical approvals, and conflict-of-interest disclosures.
Publication Ethics & Integrity
Journal of Oncology and Cancer Research is committed to maintaining the highest publication ethics standards in accordance with COPE principles.
Authors must ensure proper ethical approvals for studies involving humans, animals, or sensitive materials, and follow informed consent and confidentiality practices.
They must also disclose conflicts of interest and funding support, report data accurately, and acknowledge contributor roles.
All submissions undergo plagiarism checks, and the journal has a strict policy for corrections, retractions, and post-publication updates.
